Audit-ready analysis plans and reproducible results
Biostatistics & Evidence for Successful Studies and Regulatory Submissions
We provide biostatistical support in line with the latest guidelines, covering everything from sample size planning and randomisation to Statistical Analysis Plans (SAPs) and analyses.
You will receive submission-ready, validated results with auditable documentation, reproducible calculations and clear visualisations, enabling you to execute your study successfully.
Tailored Exactly to Your Needs!
All of our services can be booked either individually or as a complete package.
This applies to pivotal studies and projects in academic and technological research. We provide targeted support, whether your studies are subject to regulatory requirements or are purely scientific in nature.
Your Benefits with TRIGA-S
Evidence Ready for Submission
We provide Statistical Analysis Plans (SAPs) and Statistical Analysis Reports (SARs), as well as validated analyses that are ready for audit and can be submitted directly to competent authorities.
Reduced Study Risks
Conservative sample size planning and clear acceptance criteria, in line with current guidelines, minimise the risk of additional recruitment and early study termination.
Make Faster Decisions
Thanks to clear visualisations and coordinated processes across data collection, review and analysis, you always know where you stand.
Efficient Execution
When planning, monitoring and analysis work together seamlessly, you save time and avoid unnecessary work.
Traceable and Audit-Ready
Every assumption is documented and every calculation is reproducible, ensuring complete traceability during audits and regulatory inquiries.
Our services in detail
Biostatistics & Evidence
All services at a glance – jump straight to the topic you need.
Biostatistical Consulting: Study Planning and Design
Study Design and Endpoints
We translate complex regulatory requirements, such as those of the IVDR, and your individual product goals into robust endpoints (e.g., sensitivity/specificity), analysis populations, and acceptance criteria. By following international standards such as ISO 20916, we ensure that you know from the outset which data must be collected to generate evidence.
Sample Size
As little as possible, as much as necessary: we plan your sample sizes according to current guidelines, such as CLSI or FDA requirements. Our approach is always conservative, with a buffer and clearly documented assumptions. Our goal is to avoid the need for additional recruitment.
Statistical Analysis Plan
Our Statistical Analysis Plan (SAP) leaves no stone unturned: we define your datasets, establish statistical methods, specify how missing data is handled and determine the reporting format. The SAP can either be incorporated into the protocol or maintained separately.
Randomisation
We provide traceable and reproducible plans, even for complex multi-arm CDx designs. This minimises bias and ensures a clear audit trail.
Your Data: Validated & audit-ready
Statistical Analysis & Report
We analyse your data in accordance with the SAP. All analyses follow our SOPs, are independently validated and fully documented, making them audit-ready for regulatory review. If you perform your own analyses, we can validate them to ensure the results are fit for submission.
You will receive:
- Validated analyses according to internal SOPs
- Audit-ready Statistical Analysis Report (SAR)
- Complete documentation of all analysis steps
- Optional: Validation of your own analyses
Data Visualisation
Numbers are good. Clear numbers are better. We build interactive dashboards that visualise your data. You can use them to monitor study progress and prepare results for presentations.
You can:
- Monitor study data in real time
- Analyse data descriptively
- Visually prepare results for reports
- See where you stand at any time
Post-Market Performance Follow-up (PMPF)
Even after market launch, monitoring your products remains crucial. PMPF analyses help to ensure long-term performance and safety. We conduct meta-analyses and systematically evaluate performance data to generate consolidated evidence from multiple sources. This enables us to produce reliable, audit-ready reports that are statistically sound.
We support you with:
- Systematic evaluation of performance data
- Evidence synthesis across multiple sources
- Audit-ready reports for authorities and internal quality assessments
Workshops
Does your team need assistance with study design or sample size planning? Do you need assistance in convincing stakeholders of your statistical strategy? Our workshops can be tailored to your specific requirements and are accessible to non-statisticians.
Possible topics include:
- Study design and endpoint definition for diagnostics (IVD/CDx) and pharma
- Sample size planning
- Statistical methods for clinical trials
- Correctly interpreting and communicating analysis results
Get in Touch
Would you like to discuss a specific project, ask a question, or find out more about our services? Give us a brief outline of what it’s about – we will get back to you within 48 hours.
Email Address
Phone Number
Address
TRIGA-S GmbH
Mühltal 5, 82392 Habach, Germany
Send Us a Message
You Might Also Be Interested In
Sample Management
Services
Study Management & Monitoring
Abbreviations
CDx: Companion Diagnostics
CLSI: Clinical and Laboratory Standards Institute
FDA: Food and Drug Administration
ISO 20916: ISO standard for clinical performance studies of IVDs
IVD: In vitro diagnostics
IVDR: In Vitro Diagnostic Regulation
PMPF: Post-Market Performance Follow-up
SAP: Statistical Analysis Plan
SAR: Statistical Analysis Report
SOP: Standard Operating Procedure

